Association Between Serum Homocysteine and Markers of Impaired Kidney Function in Adults in the United States
Overview
Affiliations
Background: Circulating homocysteine, a risk factor for cardiovascular disease (CVD), is often elevated in chronic kidney disease and end-stage renal disease (ESRD) patients. Little is known about the risk of elevated homocysteine associated with less advanced renal insufficiency in the community.
Methods: Serum homocysteine concentration measures (umol/L) from the National Health and Nutrition Examination Survey (NHANES) 1991-1994 participants who were aged >/=40 years and fasted >/=6 hours (1558 men and 1829 women) were categorized as <9, 9 to 11.9, 12 to 14.9, and >/=15. Renal function levels were determined by Modified Diet in Renal Disease (MDRD) estimated glomerular filtration rate (GFRest) (mL/min/1.73 m(2)) and the urinary albumin-to-creatinine ratio (ACR) (mg/g). Cumulative odds ratios (OR) of exceeding any given homocysteine cut point were computed by gender, using ordinal logistic regression. Each model included GFRest (<60, 60 to 90, >/=90), ACR (<15, 15 to <30, >/=30), age, race/ethnicity, red blood cell folate, serum vitamin B(12), and dietary vitamin B(6) intake as independent variables.
Results: The adjusted ORs for elevated homocysteine risk were 9 to 11 times greater in adults with the lowest GFRest levels (<60 mL/min/1.73 m(2)) compared to those with normal GFRest levels. Association measures for marginal GFRest levels (60 to 90 mL/min/1.73 m(2)) were weaker but significant. Albuminuria (ACR >/=30 mg/g) was a significant, independent renal risk factor for elevated homocysteine in men and women (adjusted OR = 1.78, 95% CI 1.08-2.93, and adjusted OR = 1.83, 95% CI 1.21-2.76, respectively) relative to those with low normal albumin excretion, but high normal albuminuria (ACR = 15-30 mg/g) was not.
Conclusion: In the general population, renal insufficiency is strongly associated with an increased risk of elevated circulating homocysteine, independent of B vitamin status. These results raise the possibility that elevated homocysteine may be an important risk factor to explain the heavy burden of CVD associated with kidney disease.
Serum and urinary uromodulin concentration in children and young adults with chronic kidney disease.
Golob Jancic S, Mocnik M, Filipic M, Homsak E, Svetej M, Marcun Varda N Pediatr Nephrol. 2025; .
PMID: 39797984 DOI: 10.1007/s00467-024-06630-z.
Association between Homocysteine and Vitamin D Levels in Asymptomatic Korean Adults.
Lee Y, Kang S, Song S, Kim S Nutrients. 2024; 16(8).
PMID: 38674846 PMC: 11054723. DOI: 10.3390/nu16081155.
Bouazza A, Tahar A, AitAbderrhmane S, Saidani M, Koceir E Ren Fail. 2022; 44(1):1243-1262.
PMID: 35930297 PMC: 9359195. DOI: 10.1080/0886022X.2022.2106244.
Effect of denosumab on renal function in women with osteoporosis evaluated using cystatin C.
Ohishi T, Fujita T, Nishida T, Hagiwara K, Murai R, Matsuyama Y Osteoporos Sarcopenia. 2022; 8(2):68-74.
PMID: 35832419 PMC: 9263171. DOI: 10.1016/j.afos.2022.05.002.
Liang S, Liu H, Liu S, Wei M, Gao F, Xue J RSC Adv. 2022; 9(54):31720-31727.
PMID: 35527928 PMC: 9072727. DOI: 10.1039/c9ra04248b.